14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CLDX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Celldex Therapeutics stock price after Thursday trading.
(Updated on May 02, 2024)

Buy candidate since May 02, 2024 PDF

The Celldex Therapeutics stock price gained 3.84% on the last trading day (Thursday, 2nd May 2024), rising from $39.35 to $40.86. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 5.68% from a day low at $38.75 to a day high of $40.95. The price has risen in 6 of the last 10 days and is up by 6.05% over the past 2 weeks. Volume fell on the last day by -310 thousand shares and in total, 551 thousand shares were bought and sold for approximately $22.51 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.52% during the next 3 months and, with a 90% probability hold a price between $34.03 and $47.08 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CLDX Signals & Forecast

Mostly positive signals in the chart today. The Celldex Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $37.74 and $39.83. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 12.69%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Celldex Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $38.25 and $37.75. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Celldex Therapeutics finds support just below today's level at $38.25. If this is broken, then the next support from accumulated volume will be at $37.75 and $36.26.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.20 between high and low, or 5.68%. For the last week, the stock has had daily average volatility of 5.10%.

Our recommended stop-loss: $39.49 (-3.36%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (CLDX) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Celldex Therapeutics to open at $40.19, and during the day (based on 14 day Average True Range), to move between $39.03 and $42.69, which gives a possible trading interval of +/-$1.83 (+/-4.49%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 8.98% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $38.25 (6.39%) than the resistance at $48.23 (18.04%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Celldex Therapeutics stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 3.033 Buy Candidate Upgraded

Predicted Opening Price for Celldex Therapeutics of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$40.19 ( 1.65%) $40.86

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CLDX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 42.39 3.74 %
R2 41.55 1.68 %
R1 41.03 0.409 %
Current price: 40.86
Support S1 39.35 -3.70 %
S2 38.83 -4.98 %
S3 37.99 -7.03 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 51.04 24.91 %
R2 50.01 22.39 %
R1 48.23 18.04 %
Current price 40.86
Support S1 38.25 -6.39%
S2 37.75 -7.61%
S3 36.26 -11.26%

FAQ

What is the symbol for Celldex Therapeutics Stock and on which exchange is it traded?
The symbol for Celldex Therapeutics is CLDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Celldex Therapeutics Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Celldex Therapeutics Stock?
Celldex Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Celldex Therapeutics Stock.

What's the current price of Celldex Therapeutics Stock?
As of the end of day on the May 02, 2024, the price of an Celldex Therapeutics (CLDX) share was $40.86.

What is the 52-week high and low for Celldex Therapeutics Stock?
The 52-week high for Celldex Therapeutics Stock is $53.18 and the 52-week low is $22.11.

What is the market capitalization of Celldex Therapeutics Stock?
As of the May 02, 2024, the market capitalization of Celldex Therapeutics is 2.693B.

When is the next earnings date for Celldex Therapeutics?
The upcoming earnings date for Celldex Therapeutics is Aug 06, 2024.
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT